A meta-analysis revealed that for each kilogram of weight loss, patients typically experience at least a 1 mmHg reduction in blood pressure [4]
The question is whether the company can scale its support infrastructure to match its patient growth
One emerging therapy that aligns with our mission of comprehensive perioperative care is BPC -157 peptide therapy
Newer agents like survodutide , orforglipron , or mazdutide are in various stages of development and clinical use, and retatrutide (a triple agonist targeting GIP, GLP-1, and glucagon receptors) shows even greater weight loss potential than tirzepatide in early trials
doi: 10.1056/NEJMoa0810719 50 GowN
To get started, complete your intake form and book your 1-on-1 assessment with one of our weight loss experts